Resonance Health vs Veeva Systems Inc Class A: Fair Value & Quality
Both stocks run through our valuation models. Here is how Resonance Health (RHT) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Resonance Health as the less overvalued of the two: Resonance Health trades at A$0.06 versus a fair value of A$0.03 (-40%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Resonance Health
RHT.AU · AUD · Health Care
-40%
upside to fair value
overvalued
PriceA$0.06
Fair ValueA$0.03
Quality55/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-59%
upside to fair value
overvalued
Price$230
Fair Value$95.12
Quality72/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Resonance HealthVeeva Systems Inc Class A
Valuation
—P/E (TTM)33.6×
1.10×P/S (TTM)9.31×
1.61×P/B4.28×
13.2×EV/EBITDA28.7×
2.55×PEG0.85×
Profitability
6%Net margin28%
16%Operating margin31%
7%Return on equity14%
3%Return on assets7%
Growth
53%Revenue growth (YoY)16%
42.5%Avg. growth/yr (3Y)14.0%
24.7%Avg. growth/yr (5Y)16.9%
Balance & size
0.27×Debt / equity—
$15MMarket cap$31B
mixedGrowth qualityhealthy
Resonance Health leads: 6 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Resonance Healthof which business quality 53 · market factors 59Veeva Systems Inc Class Aof which business quality 72 · market factors 48
ProfitabilityMargins and returns on capital today
28
57
Quality GrowthAre margins and returns improving?
50
65
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
71
33
Low VolatilityCalm price path (market factor)
28
55
MomentumPrice trend over the last 3–12 months (market factor)
64
52
52W MomentumDistance to the 52-week high (market factor)
87
31
Net IssuanceBuybacks instead of dilution
85
72
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Resonance Health
DCF ModelsA$0.03
MultiplesA$0.02
Asset-BasedA$0.01
Growth DCFA$0.03
7 of 7 models see the stock below the current price.
Veeva Systems Inc Class A
DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185
21 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Resonance Health
Bear A$0.03Fair Value A$0.03Bull A$0.04
A$0.06 = current price (white tick)
Veeva Systems Inc Class A
Bear $71.34Fair Value $95.12Bull $146
$230 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Resonance Health · Health Care
Quality score55 · above median
Fair value upside-40% · below median
Veeva Systems Inc Class A · Health Care
Quality score72 · Top 25%
Fair value upside-59% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Resonance Health as the less overvalued of the two: Resonance Health trades at A$0.06 versus a fair value of A$0.03 (-40%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Veeva Systems Inc Class A has the higher quality score (72/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
